Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) FCF Margin: 2015-2025

Historic FCF Margin for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -5,691.91%.

  • AC Immune's FCF Margin fell 563707.00% to -5,691.91% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,970.72%, marking a year-over-year decrease of 212708.00%. This contributed to the annual value of 238.99% for FY2024, which is 65537.00% up from last year.
  • Per AC Immune's latest filing, its FCF Margin stood at -5,691.91% for Q3 2025, which was down 369.62% from -1,212.02% recorded in Q2 2025.
  • AC Immune's 5-year FCF Margin high stood at 3,581.10% for Q2 2022, and its period low was -350,100.00% during Q3 2021.
  • Moreover, its 3-year median value for FCF Margin was -3,908.91% (2023), whereas its average is -13,728.00%.
  • In the last 5 years, AC Immune's FCF Margin tumbled by 34,873,339bps in 2021 and then soared by 34,975,600bps in 2022.
  • AC Immune's FCF Margin (Quarterly) stood at -29,834.67% in 2021, then soared by 2,478,530bps to -5,049.36% in 2022, then crashed by 34,639bps to -5,395.76% in 2023, then surged by 582,425bps to 428.50% in 2024, then slumped by 563,707bps to -5,691.91% in 2025.
  • Its FCF Margin stands at -5,691.91% for Q3 2025, versus -1,212.02% for Q2 2025 and -1,918.79% for Q1 2025.